At UiPath’s Fusion London event, NFU Mutual’s automation lead explains how the UK insurer built a working agentic claims ...
Parallel has raised $20M to deploy AI agents that automate medical coding and billing directly on top of existing hospital ...
Martin Oswald, Head of Operational Transformation at Travelodge, explains how a deliberate, colleague-first approach to ...
It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.
UiPath (PATH) stock is selling off despite strong earnings as the market has not yet priced in whether agentic AI automation will accelerate enterprise adoption the way it did for Palantir ...
UiPath Inc. beat expectations on earnings and revenue in its latest financial results, doubled its profitability and offered ...
ServiceNow has been growing its revenue quickly and has a big potential driver with its Control Tower solution. UiPath's stock is very cheap, and it has a huge potential opportunity in AI agent ...
From fiscal 2021 to fiscal 2025 (which ended last January), UiPath's revenue rose at a 24% CAGR. Unfortunately, its growth decelerated over the final three years, increasing just 9% in fiscal 2025. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results